REGN - Regeneron Pharmaceuticals
Earnings Results

Regeneron Pharmaceuticals ( $REGN )

Recent earnings result

Events & Presentations

Regeneron Oncology Strategy

Supporting docs

  1. PDF document

Top Stories (REGN)

Events & Annual meetings

Title Date Webcast
Jefferies 2019 London Healthcare Conference NOV 20 9:00 AM EST
Credit Suisse 28th Annual Healthcare Conference NOV 12 10:00 AM EST webcast
Regeneron Pharmaceuticals Q3 2019 Earnings Conference Call NOV 5, 2019 8:30 AM EST webcast
Regeneron Oncology Strategy NOV 5, 2019 PDF
European Society For Medical Oncology (ESMO) Congress 2019 SEP 30 2019 PDF

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.

Videos about Regeneron Pharmaceuticals


The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading